Cytokinetics (CYTK)
Cytokinetics EBITDA Margin TTM: -891.8%
View CYTK EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CYTK EBITDA Margin TTM Rankings
| Overall | 1st percentile | 3805 of 3847 |
| Sector | 6th percentile | 422 of 450 in Healthcare |
| Industry | 13th percentile | 105 of 122 in Biotechnology |
CYTK EBITDA Margin TTM Range, Past 5 Years
| Minimum | -1938% | Sep 2010 |
| Maximum | 35.19% | Sep 2009 |
| Average | -726.9% |
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these CYTK related companies
CYTK News
$CYTK forms bearish "Continuation Diamond" chart pattern. http://stks.co/3aqN
about 28 days ago by RecogniaEvents
about 28 days ago by RecogniaEvents
@Jamtrades @seekingalpha when they use the term encouiraging it usually means its crap $CYTK
about 33 days ago by lieberlanz
about 33 days ago by lieberlanz
Cytokinetics (CYTK) Proposed Muscle Troponin Activator Now on FDA's Fast Track
Apr 19, 8:53AM Street Insider
Apr 19, 8:53AM Street Insider
$CYTK forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/3IOW
about 48 days ago by RecogniaEvents
about 48 days ago by RecogniaEvents
$CYTK filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3BjU
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
Cytokinetics to Present at the Eleventh Annual Needham Life Sciences Conference
Mar 27, 4:13PM Marketwire
Mar 27, 4:13PM Marketwire
@ChiBullsTrader @ChillzTrading Agree! May add position for that event; already have $CYTK for the same conference.
about 68 days ago by Chilltill
about 68 days ago by Chilltill
$CYTK forms bullish "Diamond Bottom" chart pattern. http://stks.co/2kad
about 81 days ago by RecogniaEvents
about 81 days ago by RecogniaEvents
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Feb 02, 4:13PM Street Insider
Feb 02, 4:13PM Street Insider
Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and 2011 Financial Results
Feb 02, 4:00PM Marketwire
Feb 02, 4:00PM Marketwire
Cytokinetics to Announce Fourth Quarter and Year End Results on February 2, 2012
Jan 26, 4:00PM Marketwire
Jan 26, 4:00PM Marketwire
Cytokinetics (CYTK) Reports Positive CK-2017357 Phase II, Part A Dat in ALS Patients
Nov 30, 7:32AM Street Insider
Nov 30, 7:32AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CYTK | 0.93 | +0.02 | +2.20% | 71.03M |
| CVBK | 0.86 | -0.08 | -8.51% | 2.262M |
| CVA | 15.79 | -0.03 | -0.19% | 2.149B |
| CV | 35.13 | -0.02 | -0.06% | 473.55M |
| CUZ | 7.42 | +0.09 | +1.23% | 772.72M |
| CUTR | 6.94 | -0.20 | -2.80% | 96.81M |
| CUT | 16.04 | +0.04 | +0.24% | |
| CURE | 39.59 | +0.00 | +0.00% | |
| CUR | 0.94 | -0.01 | -1.05% | 51.40M |
| CUK | 32.44 | +0.02 | +0.06% | 6.977B |
